Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Skin Neoplasms

Skin Diseases

Dermatologic Agents

All Drugs and Chemicals

The aim of the first part of the study is to evaluate patients' skin monitoring habits, their knowledge of skin cancer, and their preconceptions about new telemedicine tools such as teledermoscopy. This is a written quantitative questionnaire with answers to tick.

An explanatory folder will be given to patients and they will be asked to read it beforehand in order to allow a good understanding of the terms used and the goal of the project. This part will include 70 to 100 patients.

The second part of the study is a qualitative study and the aim of it is to evaluate the satisfaction, acceptance and future expectations of those who have benefited from teledermoscopy. Individual and anonymous interviews, lasting 15 to 20 minutes, intended for patients who have benefit of teledermoscopy at the office. An explanatory folder will also be given to the patients concerned in order to explain to them the procedure of the interview. This part will include 8 to 10 patients.

If there is any diagnostic doubt about a skin lesion, teledermoscopy will be used, if the patient agrees.

* A table containing the useful information about the patient for the lesion's analysis will be completed.
* The pictures will be taken with a Fotofinder Handyscope. The photos will be integrated into the patient's electronic medical record (CareConnect program).
* The photo is anonymized via a serial number assigned by the "Handyscope" application.
* Sending photos and information via a secure email address to the dermatologists.
* Response from the dermatologist (Prof. Tromme or Dr Harkemanne) in the following days also via email.
* Contact (consultation or telephone call depending on the diagnosis) with the patient to communicate the results and the procedure to be followed.
* This information (emails containing the dermatological report) will be saved in the patient's computerized medical file (CareConnect program) then deleted from the mailbox

taking macroscopic and dermoscopic pictures of suspicious skin lesions

Odile MAGOTTEAUX, Dr

Isabelle Tromme, Dr

The aim objective of this work is to assess the characteristics of patients for whom teledermoscopy could be suitable for the detection of potential skin cancers, within a population of rural general medicine in the South of Hainaut, by means of a mixed quantitative and qualitative study corresponding respectively:

* To identify patients' knowledge of skin cancers, their skin monitoring habits, and their acceptability of new telemedicine tools such as teledermoscopy ("Part 1").
* To evaluate the satisfaction and expectations of those who benefit from teledermoscopy ("Part 2").

Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area

Evaluation of Patients Acceptance and Satisfaction With Teledermoscopy at the General Practionner's Office for the Detection of Skin Cancer in a Rural Area.

Using a quantitative survey-type questionnaire

* Determination of the patients ' skin monitoring habits
* Determination of patients' knowledge of skin cancers and their prevention
* Determine their acceptance of new technologies such as teledermoscopy in the context of skin cancer screening
* And finally, determination of a target population for whom teledermoscopy could be suitable for the detection of skin cancers (percentage of patients accepting teledermoscopy etc)

Assessment of the satisfaction and future expectations of patients who have benefited from teledermoscopy in general practice, using a qualitative study in the form of semi-structured, individual and anonymous interviews

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Rare Diseases

Melanoma

Melanoma, Cutaneous Malignant

Neuroendocrine Tumors

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms by Histologic Type

Neoplasms, Nerve Tissue

Nevus, Pigmented

Nevus

Nevi and Melanomas

Neuroendocrine Tumor

Neuroepithelioma

We will send 3 sets of materials via mail, containing information about melanoma prevention and detection, 1 set each month for 3 months. Materials published by:

* The American Cancer Society
* The American Academy of Dermatology
* The Skin Cancer Foundation

The pamphlets contain information about ways to reduce risk for skin cancer including:

* Sun protection practices
* Risk factors for melanoma
* Information about what melanoma looks like
* How to do skin self-examinations

There will also be a telephone discussion with a health educator, discussing melanoma and other information contained in the pamphlets.

Reading materials and discussions

We will send 3 separate pamphlets created specifically for participants. We will send 1 pamphlet each month for 3 months. The information in the pamphlets will be based on answers from the first survey. These pamphlets will contain information about:

* Melanoma and skin cancer protection guidelines
* The benefits of skin screening practices
* Ways to protect yourself from the sun

In addition to these pamphlets, there will be a telephone discussion with a health educator to discuss melanoma and other information contained in the pamphlets.

Both groups will complete 3 surveys; at the beginning, 3 months later, 6 months after the second survey. Each survey will ask about:

* knowledge of melanoma
* current and past skin cancer screening practices
* current and past sun protection practices
* attitudes about skin cancer and sun protection
* feelings about relative's melanoma diagnosis and treatment

Questionnaires

Paul Jacobsen, Ph.D.

Sharon L Manne, PhD

Michael Ming, MD

The purpose of the investigators' study is to find the best way to provide information about sun protection and skin cancer detection. The investigators want to see which of two methods most improves sun protection and screening attitudes and practices. The investigators hope to improve these attitudes and practices among people who are at higher risk for melanoma. People at higher risk for melanoma are first degree relatives (mother, father, sibling or child) of people diagnosed with melanoma.

Eligible patients will be contacted to find out whether they have any living first degree relatives that we may contact to discuss their participation in our study.

Eligible first degree relatives (FDRs) will participate in our study as outlined under Interventions.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area	NCT04534868	Skin Cancer Patient Accepta... Patient Satisfa...	taking macrosco...	18 Years -	Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Tailored Intervention for Melanoma Patient's Families	NCT00816374	Melanoma	Reading materia... Reading materia... Questionnaires	21 Years -	Fox Chase Cancer Center

Spots Global Cancer Trial Database for skin cancer screening